UnitedHealth Group Incorporated $UNH Stake Raised by Bank Hapoalim BM

Bank Hapoalim BM grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 154.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,888 shares of the healthcare conglomerate’s stock after buying an additional 2,357 shares during the period. Bank Hapoalim BM’s holdings in UnitedHealth Group were worth $1,213,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. AMF Tjanstepension AB raised its holdings in UnitedHealth Group by 30.1% during the second quarter. AMF Tjanstepension AB now owns 309,549 shares of the healthcare conglomerate’s stock worth $96,629,000 after purchasing an additional 71,585 shares in the last quarter. Future Financial Wealth Managment LLC raised its holdings in UnitedHealth Group by 164.9% during the second quarter. Future Financial Wealth Managment LLC now owns 1,486 shares of the healthcare conglomerate’s stock worth $464,000 after purchasing an additional 925 shares in the last quarter. Hennessy Advisors Inc. bought a new stake in UnitedHealth Group during the second quarter worth approximately $109,000. Ameriflex Group Inc. raised its holdings in UnitedHealth Group by 5.0% during the second quarter. Ameriflex Group Inc. now owns 1,938 shares of the healthcare conglomerate’s stock worth $587,000 after purchasing an additional 92 shares in the last quarter. Finally, ZWJ Investment Counsel Inc. raised its holdings in UnitedHealth Group by 1.8% during the second quarter. ZWJ Investment Counsel Inc. now owns 3,270 shares of the healthcare conglomerate’s stock worth $1,020,000 after purchasing an additional 59 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.8%

NYSE UNH opened at $360.17 on Friday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market cap of $326.20 billion, a price-to-earnings ratio of 15.61, a PEG ratio of 2.30 and a beta of 0.47. The firm’s 50 day moving average price is $307.84 and its two-hundred day moving average price is $355.58.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter in the prior year, the firm earned $6.80 earnings per share. The company’s revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s payout ratio is currently 38.30%.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on UNH. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of UnitedHealth Group in a report on Saturday, September 27th. KeyCorp dropped their price target on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a report on Wednesday, July 30th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Baird R W cut UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Finally, JPMorgan Chase & Co. lowered their price objective on shares of UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 6th. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $358.95.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.